XERS
XERS
NASDAQ · Pharmaceuticals

Xeris Biopharma Holdings Inc

$7.93
+0.57 (+7.74%)
As of Aug 8, 10:10 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +488.3% upside
Low Target $35.62
Average Target $46.65
High Target $60.75
Current Price $7.93
Current
$7.93
Target
$46.65
$35.62 $46.65 avg $60.75
Scenario Analysis
Bear Case
$35.62
349.2%
Low target
Base Case
$46.65
+488.3%
Avg target
Bull Case
$60.75
+666.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-21.3% from high
52-Week Low
$5.25
+51.0% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%